斑秃患者眉毛和睫毛对托法替布治疗的反应 - Suppr

Suppr

超能文献

Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata.

作者信息

Liu Lucy Y, King Brett A

机构信息

Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut.

出版信息

J Am Acad Dermatol. 2019 Jun;80(6):1778-1779. doi: 10.1016/j.jaad.2018.11.037. Epub 2018 Nov 28.

DOI:10.1016/j.jaad.2018.11.037

PMID:30502414

Abstract

摘要

相似文献

Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata.

J Am Acad Dermatol. 2019 Jun;80(6):1778-1779. doi: 10.1016/j.jaad.2018.11.037. Epub 2018 Nov 28.

Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis.

J Am Acad Dermatol. 2018 Jun;78(6):1207-1209.e1. doi: 10.1016/j.jaad.2018.02.031.

An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.

J Drugs Dermatol. 2018 Aug 1;17(8):914-917.

Response of alopecia areata of the beard to oral tofacitinib.

J Am Acad Dermatol. 2020 May;82(5):1228-1230. doi: 10.1016/j.jaad.2019.10.058. Epub 2019 Oct 31.

Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients.

Dermatol Ther. 2019 May;32(3):e12844. doi: 10.1111/dth.12844. Epub 2019 Feb 7.

Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series.

J Am Acad Dermatol. 2017 Nov;77(5):978-980. doi: 10.1016/j.jaad.2017.06.027.

Tofacitinib as a treatment of alopecia areata in adolescents.

Bol Med Hosp Infant Mex. 2019;76(4):182-187. doi: 10.24875/BMHIM.19000005.

Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen.

Eur J Dermatol. 2019 Dec 1;29(6):667-669. doi: 10.1684/ejd.2019.3668.

Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents.

J Investig Dermatol Symp Proc. 2018 Jan;19(1):S18-S20. doi: 10.1016/j.jisp.2017.10.003.

Tofacitinib therapy for children with severe alopecia areata.

J Am Acad Dermatol. 2019 Apr;80(4):1164-1166. doi: 10.1016/j.jaad.2018.12.041. Epub 2019 Jan 8.

引用本文的文献

Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata.

Am J Clin Dermatol. 2024 Nov;25(6):975-986. doi: 10.1007/s40257-024-00884-x. Epub 2024 Sep 3.

Treatment Options for Alopecia Areata in Children and Adolescents.

Paediatr Drugs. 2024 May;26(3):245-257. doi: 10.1007/s40272-024-00620-2. Epub 2024 Mar 11.

Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata.

Dermatol Ther (Heidelb). 2023 Dec;13(12):3209-3220. doi: 10.1007/s13555-023-01063-2. Epub 2023 Nov 22.

Alopecia Areata: An Updated Review for 2023.

J Cutan Med Surg. 2023 May-Jun;27(3):241-259. doi: 10.1177/12034754231168839.

The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients.

Front Immunol. 2023 Jun 2;14:1195858. doi: 10.3389/fimmu.2023.1195858. eCollection 2023.

Eyebrow and Eyelash Alopecia: A Clinical Review.

Am J Clin Dermatol. 2023 Jan;24(1):55-67. doi: 10.1007/s40257-022-00729-5. Epub 2022 Oct 2.

Ocular Toxicity of Targeted Anticancer Agents.

Drugs. 2021 May;81(7):771-823. doi: 10.1007/s40265-021-01507-z. Epub 2021 Mar 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata.

J Am Acad Dermatol. 2019 Jun;80(6):1778-1779. doi: 10.1016/j.jaad.2018.11.037. Epub 2018 Nov 28.

Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis.

J Am Acad Dermatol. 2018 Jun;78(6):1207-1209.e1. doi: 10.1016/j.jaad.2018.02.031.

An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.

J Drugs Dermatol. 2018 Aug 1;17(8):914-917.

Response of alopecia areata of the beard to oral tofacitinib.

J Am Acad Dermatol. 2020 May;82(5):1228-1230. doi: 10.1016/j.jaad.2019.10.058. Epub 2019 Oct 31.

Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients.

Dermatol Ther. 2019 May;32(3):e12844. doi: 10.1111/dth.12844. Epub 2019 Feb 7.

Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series.

J Am Acad Dermatol. 2017 Nov;77(5):978-980. doi: 10.1016/j.jaad.2017.06.027.

Tofacitinib as a treatment of alopecia areata in adolescents.

Bol Med Hosp Infant Mex. 2019;76(4):182-187. doi: 10.24875/BMHIM.19000005.

Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen.

Eur J Dermatol. 2019 Dec 1;29(6):667-669. doi: 10.1684/ejd.2019.3668.

Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents.

J Investig Dermatol Symp Proc. 2018 Jan;19(1):S18-S20. doi: 10.1016/j.jisp.2017.10.003.

Tofacitinib therapy for children with severe alopecia areata.

J Am Acad Dermatol. 2019 Apr;80(4):1164-1166. doi: 10.1016/j.jaad.2018.12.041. Epub 2019 Jan 8.

引用本文的文献

Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata.

Am J Clin Dermatol. 2024 Nov;25(6):975-986. doi: 10.1007/s40257-024-00884-x. Epub 2024 Sep 3.

Treatment Options for Alopecia Areata in Children and Adolescents.

Paediatr Drugs. 2024 May;26(3):245-257. doi: 10.1007/s40272-024-00620-2. Epub 2024 Mar 11.

Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata.

Dermatol Ther (Heidelb). 2023 Dec;13(12):3209-3220. doi: 10.1007/s13555-023-01063-2. Epub 2023 Nov 22.

Alopecia Areata: An Updated Review for 2023.

J Cutan Med Surg. 2023 May-Jun;27(3):241-259. doi: 10.1177/12034754231168839.

The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients.

Front Immunol. 2023 Jun 2;14:1195858. doi: 10.3389/fimmu.2023.1195858. eCollection 2023.

Eyebrow and Eyelash Alopecia: A Clinical Review.

Am J Clin Dermatol. 2023 Jan;24(1):55-67. doi: 10.1007/s40257-022-00729-5. Epub 2022 Oct 2.

Ocular Toxicity of Targeted Anticancer Agents.

Drugs. 2021 May;81(7):771-823. doi: 10.1007/s40265-021-01507-z. Epub 2021 Mar 31.